Leon, Spain

Manuel Oliver Ruiz

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Antibioticos, S.a.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manuel Oliver Ruiz. Retrieved from https://idiyas.com/inventor/manuel-oliver-ruiz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manuel Oliver Ruiz: Innovator in Pharmaceutical Chemistry

Introduction

Manuel Oliver Ruiz is a notable inventor based in Leon, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the production of important compounds.

Latest Patents

Manuel holds a patent for a process for producing 6-amino-penicillanic acid and phenylacetic acid. This innovation is crucial for the development of various antibiotics and has implications in the pharmaceutical industry.

Career Highlights

Throughout his career, Manuel has worked with prominent companies such as Antibioticos, S.A. and Vitatene, S.A. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug production.

Collaborations

Manuel has collaborated with Emiliano Gonzalez De Prado, enhancing his research and development efforts in the pharmaceutical sector.

Conclusion

Manuel Oliver Ruiz is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the industry positively. His innovative processes and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…